首页> 外国专利> BENZOFURAN,-PYRAN AND -DIOXAN-2-YLALKYLAMINOALKYL SUBSTITUTED GUANIDINE DERIVATIVES; PHARMACEUTICAL COMPOSITIONS; PREPARATORY METHODS AND INTERMEDIATES

BENZOFURAN,-PYRAN AND -DIOXAN-2-YLALKYLAMINOALKYL SUBSTITUTED GUANIDINE DERIVATIVES; PHARMACEUTICAL COMPOSITIONS; PREPARATORY METHODS AND INTERMEDIATES

机译:苯并呋喃,-吡喃和-二氧杂-2-基烷基酰胺基烷基取代的胍基衍生物;药物成分;制备方法和中间体

摘要

PCT No. PCT/EP93/00435 Sec. 371 Date Jul. 29, 1994 Sec. 102(e) Date Jul. 29, 1994 PCT Filed Feb. 19, 1993 PCT Pub. No. WO93/17017 PCT Pub. Date Sep. 2, 1993The present invention is concerned with vasoconstricive [(benzodioxan, benzofuran or benzopyran)alkylamino]alkyl substituted guanidines having the formula IMAGE (I) the pharmaceutically acceptable acid addition salts thereof, and the stereochemically isomeric forms thereof, wherein X is O, CH2 or a direct bond; R1 is hydrogen or C1-6alkyl; R2 is hydrogen, C1-6alkyl, C3-6alkenyl or C3-6alkynyl; R3 is hydrogen or C1-6alkyl; or R2 and R3 may be taken together to form a bivalent radical of formula -(CH2)m-, wherein m is 4 or 5; or R1 and R2 taken together may form a bivalent radical of formula -CH=CH- or of formula -(CH2)n-, wherein n is 2, 3 or 4; or R3 may represent a bond when R1 and R2 taken together form a bivalent radical of formula -CH=CH-CH=, -CH=CH-N=, or -CH=N-CH=; R4 is hydrogen or C1-6alkyl;Alk1 is a bivalent C1-3alkanediyl radical; A is a bivalent radical of formula: IMAGE (a) IMAGE (b) IMAGE (c) IMAGE (d) IMAGE (e) wherein each R5 is hydrogen or C1-4alkyl; wherein each R6 is hydrogen or C1-4alkyl; Alk2 is C2-15alkanediyl or C5-7cycloalkanediyl; and each p is 0, 1 or 2; provided that [2-[(2,3-dihydro-1,4-benzodioxin-2-yl)methyl]amino]ethyl guanidine is excluded. Pharmaceuticals which are useful as vasoconstrictors. Compositions comprising said guanidine derivatives as active ingredients, processes for preparing said guanidine derivatives and novel N-cyano guanidine, intermediates; and a use as a medicine are described.
机译:PCT号PCT / EP93 / 00435第二部分371日期1994年7月29日秒102(e)日期,1994年7月29日PCT,1993年2月19日提交,PCT Pub。 WO93 / 17017 PCT公开号1993年9月2日,本发明涉及具有式的血管收缩的[(苯并二恶烷,苯并呋喃或苯并吡喃)烷基氨基]烷基取代的胍(I)其药学上可接受的酸加成盐及其立体化学异构体形式,其中X为O,CH 2或直接键; R1是氢或C1-6烷基; R 2是氢,C 1-6烷基,C 3-6烯基或C 3-6炔基; R3是氢或C1-6烷基; R 2和R 3可一起形成式-(CH 2)m-的二价基团,其中m为4或5;或R 1和R 2一起可以形成式-CH = CH-或式-(CH 2)n-的二价基团,其中n是2、3或4;当R 1和R 2一起形成式-CH = CH-CH =,-CH = CH-N =或-CH = N-CH =的二价基团时,R 3表示键。 R4是氢或C1-6烷基; Alk1是二价C1-3烷二基; A为下式的二价基团:(IM)>(a)(b)(c)(d)(e)其中每个R 5为氢或C 1-4烷基;其中每个R 6是氢或C 1-4烷基; Alk2是C2-15烷二基或C5-7环烷​​二基;每个p为0、1或2;条件是排除[2-[((2,3-二氢-1,4-苯并二恶英-2-基)甲基]氨基]乙基]胍。可用作血管收缩剂的药物。包含所述胍衍生物作为活性成分的组合物,制备所述胍衍生物和新型N-氰基胍的方法,中间体;描述了其作为药物的用途。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号